PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.\', \'Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA. jschiffe@fredhutch.org.\', \'Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.\', \'Department of Medicine, University of Washington, Seattle, WA, USA.\']
?:citedBy
  • -1
?:creator
?:doi
  • eabc711210.1126/sciadv.abc7112
?:doi
?:hasPublicationType
?:journal
  • Science advances
is ?:pmid of
?:pmid
?:pmid
  • 33097472
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 5.817
?:rankingScore_hIndex
  • 46
?:title
  • Potency and timing of antiviral therapy as determinants of duration of SARS-CoV-2 shedding and intensity of inflammatory response.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all